Skip to main content

ORIGINAL RESEARCH article

Front. Nutr.
Sec. Clinical Nutrition
Volume 12 - 2025 | doi: 10.3389/fnut.2025.1503815

Association of dietary intake of saturated fatty acids with obstructive sleep apnea: mediating effects of Life's Crucial 9

Provisionally accepted
  • 1 Ningxia Medical University, Yinchuan, Ningxia, China
  • 2 Huadong Hospital, Fudan University, Shanghai, Shanghai Municipality, China
  • 3 Department of Cardiovascular Surgery, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
  • 4 First Clinical Medical College, Nanjing Medical University, Nanjing, Jiangsu Province, China

The final, formatted version of the article will be published soon.

    Background: Obstructive sleep apnea (OSA) is a global public health issue. Life's Crucial 9 (LC9) is recognized as a powerful tool for assessing cardiovascular health. Although the etiology of OSA remains unclear, saturated fatty acids (SFAs) and cardiovascular health are increasingly regarded as a non-negligible element. This study aims to assess the association between dietary intake of SFAs and the risk of OSA, and the mediating effect of LC9.Methods: Based on the National Health and Nutrition Examination Survey (NHANES), dietary questionnaires of participant were collected, and the average values of 24-hour dietary recall data over two days were obtained. A continuous cross-sectional analysis with dietary energy adjustment was employed. Weighted multivariable logistic regression models were used to estimate the weighted odds ratios (ORs) and their 95% confidence intervals (CIs) for SFAs and OSA. Evaluate the mediating role of LC9 in the relationship between SFAs and OSA.Results: A total of 13,563 participants aged 20 years and above were included in this study. The intakes of Sfa 4.0 and LC9 among participants with OSA were significantly lower than those in the normal population. After adjusting for confounding factors, total SFAs could increase the risk of OSA (Moedl 1, Q3, 0.03, 1.49 (1.03, 2.15); Moedl 2, Q3, 0.04, 1.47 (1.01, 2.13)). It was emphasized that dietary intake of Sfa 12.0, Sfa 14.0, and Sfa 16.0 were protective factors for OSA, especially among participants aged 45 - 64 years and white individuals. Moreover, Sfa 12.0 exhibited a better protective effect in female participants (Q3, 0.04, 0.66 (0.45, 0.99)). In addition, the cardiovascular health score - LC9 had a mediating effect in Sfa4.0 on OSA (Proportion of mediation: -0.035, 95%CI: (-0.058, -0.01); P-value = 0.002). There was a nonlinear relationship between dietary intake of Sfa 12.0, Sfa 16.0, and Sfa 18.0 and OSA (P-Nonlinear = 0.013).Conclusions: These findings suggest that dietary mixtures of saturated fatty acids increase the risk of OSA. Among them, SFA 4:0 can increase the risk of OSA through the level of cardiovascular health. However, contrary to traditional beliefs, long-chain saturated fatty acids can reduce the risk of OSA.

    Keywords: Saturated fatty acid (SFAs), Obstructive sleep apnea (OSA), Life's Crucial 9 (LC9), Mediation, NHANES, Cross-sectional study

    Received: 29 Sep 2024; Accepted: 04 Feb 2025.

    Copyright: © 2025 Ruoyu, Chen, Cheng, Cun and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Guanghua Li, Ningxia Medical University, Yinchuan, 750004, Ningxia, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.